About: Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs
Creator	Bearman, Gonzalo Doll, Michelle Nori, Priya Godbout, Emily Patel, Payal Stevens, Michael Lee, Kimberly Mazdeyasna, Hasti Noda, Andrew
source	Medline; PMC
abstract	We describe traditional antimicrobial stewardship program (ASP) activities with a discussion of how these activities can be refocused in the setting of the COVID-19 pandemic. Additionally, we discuss possible adverse consequences of ASP attention diversion on COVID-19 response efforts and overall implications for future pandemic planning. We also discuss ASP in collaboration with other groups within health systems and how COVID-19 may affect these relationships long term. Despite the paucity of literature on Antimicrobial Stewardship and COVID-19, the potential contributions of ASPs during a pandemic are numerous. ASPs can develop strategies to identify patients with COVID-19-like-illness; this is particularly useful when these patients are missed at the time of health system entry. ASPs can also play a critical role in the management of potential drug shortages, developing local treatment guidelines, optimizing the use of antibiotics, and in the diagnostic stewardship of COVID-19 testing, among other roles. Importantly, it is often difficult to ascertain whether critically ill patients who are hospitalized with COVID-19 have concurrent or secondary bacterial infections—ASPs are ideally situated to help optimize antimicrobial use for these patients via a variety of mechanisms. ASPs are uniquely positioned to aid in pandemic response planning and relief efforts. ASPs are already integrated into health systems and play a key role in optimizing antimicrobial prescribing. As ASPs assist in COVID-19 response, understanding the role of ASPs in pandemic relief efforts may mitigate damage from future outbreaks.
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1007/s11908-020-00734-x
bibo:pmid	32834785
has license	no-cc
sha1sum (hex)	17d760a9817bd88b473741bc38e569b6079dfc92
schema:url	https://doi.org/10.1007/s11908-020-00734-x
resource representing a document's title	Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs
has PubMed Central identifier	PMC7332741
has PubMed identifier	32834785
schema:publication	Curr Infect Dis Rep
resource representing a document's body	covid:17d760a9817bd88b473741bc38e569b6079dfc92#body_text
is schema:about of	named entity 'COVID-19' named entity 'Programs' named entity 'OVERALL' named entity 'RESPONSE' named entity 'COLLABORATION' named entity 'TRADITIONAL' named entity 'THESE' named entity 'ATTENTION' named entity 'HOW' named entity 'RELATIONSHIPS' named entity 'ASP' named entity 'long' named entity 'microbiology' named entity 'nosocomial infections' named entity 'expanded access' named entity 'COVID-19 pandemic' named entity 'clinical guidelines' named entity 'infection prevention' named entity 'infection prevention' named entity 'drug resistance' named entity 'molecular diagnostics' named entity 'lopinavir/ritonavir' named entity 'hydroxychloroquine' named entity 'Nursing staff' named entity 'PCR test' named entity 'preprints' named entity 'PubMed' named entity 'antimicrobial resistance' named entity 'EMRs' named entity 'Microbiology' named entity 'SARS-CoV-2' named entity 'COVID-19 response' named entity 'COVID-19 pandemic' named entity 'COVID' named entity 'COVID' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'polymerase chain reaction (PCR) test' named entity 'COVID-19 pandemic' named entity 'Mobile app' named entity 'antimicrobial therapy' named entity 'PCR test' named entity 'SARS-CoV-2' named entity 'Informed Consent' named entity 'COVID-19 pandemic' named entity 'azithromycin' named entity 'video conferencing' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'COVID-19 response' named entity 'microbiology' named entity 'COVID' named entity 'hospital-acquired infections' named entity 'antimicrobial stewardship' named entity 'rheumatologic' named entity 'health systems' named entity 'rheumatological' named entity 'infection prevention' named entity 'COVID' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'fungi' named entity 'clinical trials' named entity 'COVID-19' named entity 'de-escalation' named entity 'COVID' named entity 'critical role' named entity 'information technology' named entity 'critical role' named entity 'pharmaceutical companies' named entity 'antimicrobial' named entity 'bacterial pneumonia' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software